https://www.propublica.org/article/hhs-alicia-jackson-menopause-treatment-policy
Alicia Jackson, a top health official, endorsed an FDA policy shift on hormone therapy. She holds at least $115,000 in stock in a menopause treatment company. Ethics experts identified this as a conflict of interest.
#health #menopause #stock #hormone #policy
Alicia Jackson, a top health official, endorsed an FDA policy shift on hormone therapy. She holds at least $115,000 in stock in a menopause treatment company. Ethics experts identified this as a conflict of interest.
#health #menopause #stock #hormone #policy
Views: 4
Categories: News & Updates [c3], Projects & Resources [c5], Services [c9]